Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

7.7%

1 terminated out of 13 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

46%

6 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed with results

Key Signals

2 with results86% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (1)
Early P 1 (1)
P 1 (2)
P 2 (2)
P 3 (1)
P 4 (5)

Trial Status

Completed6
Unknown3
Terminated1
Enrolling By Invitation1
Not Yet Recruiting1
Recruiting1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
Showing all 13 trials

Research Network

Activity Timeline